Groundbreaking results from two NECTAR trials to be presented at TCT 2025 SAN FRANCISCO, Oct. 24, 2025 /PRNewswire/ — Neurotronic, Inc., a developer of multi-organ denervation to treat complex cardiovascular and …
Copyright MatchingDonors.com©️ 2025 All rights reserved.